.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Predict branded drug patent expiration
  • Identify first generic entrants

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Colorcon
Julphar
Covington
UBS
Cantor Fitzgerald
Merck
US Army
Teva
Fish and Richardson

Generated: June 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091680

« Back to Dashboard
NDA 091680 describes DIETHYLPROPION HYDROCHLORIDE, which is a drug marketed by Avanthi Inc, Sandoz, Epic Pharma Llc, Watson Labs, Teva, Ucb Inc, Tg United Labs, and Lannett Holdings Inc, and is included in ten NDAs. It is available from eight suppliers. Additional details are available on the DIETHYLPROPION HYDROCHLORIDE profile page.

The generic ingredient in DIETHYLPROPION HYDROCHLORIDE is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.

Summary for NDA: 091680

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 091680

Suppliers and Packaging for NDA: 091680

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIETHYLPROPION HYDROCHLORIDE
diethylpropion hydrochloride
TABLET, EXTENDED RELEASE;ORAL 091680 ANDA Lannett Company, Inc. 0527-1477 0527-1477-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-1477-01)
DIETHYLPROPION HYDROCHLORIDE
diethylpropion hydrochloride
TABLET, EXTENDED RELEASE;ORAL 091680 ANDA Lannett Company, Inc. 0527-1477 0527-1477-25 250 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-1477-25)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength75MG
Approval Date:Oct 24, 2011TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Moodys
US Department of Justice
Argus Health
Medtronic
Novartis
Cantor Fitzgerald
Mallinckrodt
Deloitte
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot